Prime Synthesis, Inc.
Prime Synthesis, Inc. has developed a proprietary technology to lower manufacturing costs for cutting-edge DNA and antibody-based drugs.
Prime Synthesis,Inc. manufactures and sells a key raw material that is used for making synthetic DNA and purifying antibodies. Its customers include most major pharmaceutical companies and a number of specialty biopharma firms. Over 200 synthetic DNA/RNA drugs are currently in clinical trials and many block buster antibody drugs are on the market.
A next generation product has been developed to reduce the manufacturing costs of these drugs.